Last reviewed · How we verify
inhaled nitric oxide
inhaled nitric oxide is a Small molecule drug developed by Stony Brook University. It is currently FDA-approved. Also known as: GeNOsyl(R) Delivery System, GeNOsyl(R) Acute DS, INO, standard respiratory therapy vs iNO.
At a glance
| Generic name | inhaled nitric oxide |
|---|---|
| Also known as | GeNOsyl(R) Delivery System, GeNOsyl(R) Acute DS, INO, standard respiratory therapy vs iNO, iNO |
| Sponsor | Stony Brook University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (PHASE2)
- NO Prevention of COVID-19 for Healthcare Providers (PHASE2)
- Effect of iNO in Patients With Submassive and Massive PE (PHASE2)
- Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles (NA)
- Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction. (PHASE3)
- Multiple Breathing Training on Pulmonary Function and Respiratory Muscle Strength in Older Adults (NA)
- Pulmonary Hypertension in Left Heart Disease
- The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- inhaled nitric oxide CI brief — competitive landscape report
- inhaled nitric oxide updates RSS · CI watch RSS
- Stony Brook University portfolio CI
Frequently asked questions about inhaled nitric oxide
What is inhaled nitric oxide?
inhaled nitric oxide is a Small molecule drug developed by Stony Brook University.
Who makes inhaled nitric oxide?
inhaled nitric oxide is developed and marketed by Stony Brook University (see full Stony Brook University pipeline at /company/stony-brook-university).
Is inhaled nitric oxide also known as anything else?
inhaled nitric oxide is also known as GeNOsyl(R) Delivery System, GeNOsyl(R) Acute DS, INO, standard respiratory therapy vs iNO, iNO.
What development phase is inhaled nitric oxide in?
inhaled nitric oxide is FDA-approved (marketed).
Related
- Manufacturer: Stony Brook University — full pipeline
- Also known as: GeNOsyl(R) Delivery System, GeNOsyl(R) Acute DS, INO, standard respiratory therapy vs iNO, iNO
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing